Skip to main content
OpenTrials

Clinical trial condition

Amyotrophic Lateral Sclerosis

Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.

707 public trials 173 recruiting studies
Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis trial results

Completed

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

NCT00694941

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Prof. Maloteaux, UCL Saint-Luc Brussels, Belgium
  • Prof. Wim Robberecht, UZ Leuven Leuven, Belgium
  • Prof. Alain Destee, Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
  • Prof. Philippe Couratier, Hopital Duruytren Limoges, France
View all 25 locations
View Trial Details
Completed

Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations

NCT01041222

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Familial Amyotrophic Lateral Sclerosis, +9 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital-East, Neurology Clinical Trials Unit Charlestown, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Methodist Neurological Institute Houston, Texas, United States
View Trial Details
Completed

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

NCT00244244

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00072709

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Novartis USA East Hanover, New Jersey, United States
  • Novartis Belgium Vilvoorde, Belgium
  • Novartis CANADA Dorval, Quebec, Canada
  • Novartis France Rueil-Malmaison, France
View Trial Details

Related conditions